Home > Healthcare > Medical Devices > Diagnostic Devices > Saliva Collection and Diagnostics Market

Saliva Collection and Diagnostics Market Size

  • Report ID: GMI10273
  • Published Date: Jul 2024
  • Report Format: PDF

Saliva Collection and Diagnostics Market Size

Saliva Collection and Diagnostics Market size was valued at USD 1.4 billion in 2023 and is anticipated to witness growth at a CAGR of 8.3% between 2024 and 2032, fueled by the rising incidence of chronic diseases, a shift towards minimally invasive diagnostic techniques, and increased investment in research and development.

 

Technological advances and the growing preference for non-blood diagnostic methods are driving this evolution. Furthermore, the market benefits from frequent product approvals and launches, such as Spectrum Solutions' recent introduction of SimplyPERIO in March 2024. This advanced saliva diagnostics device can detect 16 oral targets from a single saliva sample, highlighting the market's innovation and growth prospects.

 

Ongoing research and development in the saliva collection and diagnostics market are driving innovations in diagnostic methods. Saliva, rich in biomarkers like hormones, antibodies, and genetic material, offers valuable insights into health conditions such as infectious diseases, hormonal imbalances, and oral health issues. Its non-invasive, easy-to-collect nature makes saliva an attractive alternative to traditional blood or urine samples for both patients and healthcare providers, providing a convenient and effective diagnostic option.

 

The market involve the collection, analysis, and interpretation of saliva samples for medical and research purposes. It includes the use of saliva for diagnosing diseases, monitoring health conditions, conducting biomedical research, and facilitating non-invasive drug testing. This market caters to healthcare providers, research institutions, and biotechnology companies, leveraging advancements in technology to enhance the accuracy and efficiency of diagnostic procedures and personalized medicine approaches.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global saliva collection and diagnostics industry was valued at USD 1.4 billion in 2023 and is anticipated to register 8.3% CAGR between 2024 and 2032, driven by rising application of non- invasive saliva testing as a replacement of blood testing.

The submandibular/sublingual gland segment in the market held 49% revenue share in 2023 due to the unique saliva composition, ease of sample collection, and growing clinical relevance of its biomarkers.

North America saliva collection and diagnostics market is predicted to grow at 7.8% CAGR through 2032, owing to rising non-invasive testing demand and technological advancements.

Abbott Laboratories, Akonni Biosystems, Inc., Autogen, Inc., Meridian Bioscience, Inc., Neogen Inc, Norgen Biotek Corp, OraSure Technologies, Inc, Porex, and Salimetrics, LLC., among others.

Saliva Collection and Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 152
  • Countries covered: 23
  • Pages: 90
 Download Free Sample